Arcadia Biosciences Inc reports results for the quarter ended in January - Earnings Summary
13/08/2024 22:38
* Arcadia Biosciences Inc RKDA.OQ reported quarterly
adjusted
earnings of 78 cents per share for the quarter ended in
January, higher than the same quarter last year, when the
company reported EPS of $-2.65. The mean expectation of
two analysts for the quarter was for earnings of $1.55 per
share. Wall Street expected results to range from $1.27
to $1.83 per share.
* Revenue fell 6% to $1.31 million from a year ago; analysts
expected $925.00 thousand.
* Arcadia Biosciences Inc's reported EPS for the quarter was
78
cents.
* The company reported quarterly net income of $1.06
million.
* Arcadia Biosciences Inc shares had fallen by 7.3% this
quarter and lost 6.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 199.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the food
processing
peer group is also "buy"
Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $9.00
This summary was machine generated from LSEG data August 13 at
09:38 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jan. 1 0001 1.55 0.78 Missed
Mar. 31 2024 -2.21 -1.78 Beat
Dec. 31 2023 -2.58 -2.52 Beat
Sep. 30 2023 -3.19 -1.44 Beat